Research directory

Clinical trials

Find trials by company, ticker, title or NCT ID.

Filters
Reset
1,647 trials match your filters.
TrialSponsorPhaseStatusPrimary completion
A Study Evaluating the Safety, Tolerability, and Efficacy of EVO756 in Adults With Chronic Inducible UrticariaNCT06603220EVMNPhase 2Completed2025-05-08Actual
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant DiseaseNCT06607458DCTHPhase 2Recruiting2026-12Estimated
Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal AdenocarcinomaNCT06608927RCUSPhase 3Active not recruiting2030-11-30Estimated
Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4)NCT06615557VTGNPhase 3Active not recruiting2026-04-21Actual
A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study)NCT06616974Tectonic TherapeuticPhase 2Active not recruiting2026-11-24Estimated
Phase 3 Efficacy and Safety Study of GTX-102 in Pediatric Subjects With Angelman Syndrome (AS)NCT06617429RAREPhase 3Active not recruiting2026-07-10Actual
Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)NCT06625320RVMDPhase 3Active not recruiting2026-06Estimated
A Phase II Study of Intravitreal KIO-301 in Patients With Late-stage Retinitis PigmentosaNCT06628947KPRXPhase 2Recruiting2027-08Estimated
Assessment of PF614 Effects on Experimental Pain in the Cold Pressure Test (PF614-201)NCT06629402Ensysce BiosciencesPhase 2Completed2023-11-14Actual
HAELO: A Phase 3 Study to Evaluate NTLA-2002 in Participants With Hereditary Angioedema (HAE)NCT06634420Intellia TherapeuticsPhase 3Active not recruiting2026-02-10Actual
Setrusumab in Pediatric Japanese Subjects With Osteogenesis ImperfectaNCT06636071RAREPhase 3Active not recruiting2027-01Estimated
The Study Assessing the Safety and Efficacy of OK-101 Treatment in Subjects With Neuropathic Corneal PainNCT06637527OKYOPhase 2Terminated2025-04-30Actual
A Study of Olverembatinib in SDH-deficient GIST.NCT06640361Ascentage Pharma Group Inc.Phase 3Recruiting2027-03-31Estimated
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic Disease-Modifying Antirheumatic DrugNCT06641076MoonLake Immunotherapeutics AGPhase 3Active not recruiting2027-02-04Estimated
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate ResponseNCT06641089MoonLake Immunotherapeutics AGPhase 3Recruiting2027-01-15Estimated
Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).NCT06641414Ascentage Pharma Group Inc.Phase 3Recruiting2029-06Estimated
A Phase 3 Study in Moderate-to-Severe Plaque Psoriasis With Piclidenoson to Study Safety and EfficacyNCT06643260Can-Fite BioPharmaPhase 3Not yet recruiting2027-12Estimated
Suprachoroidal Administration in Subjects With Metastases to the ChoroidNCT06643884Aura BiosciencesPhase 2Recruiting2026-11-30Estimated
A Study to Assess TTI-0102 vs Placebo in MELAS PatientsNCT06644534Thiogenesis Therapeutics, Inc.Phase 2Completed2026-01-12Actual
Long-term Follow-up of Participants Treated With Galapagos Chimeric Antigen Receptor (CAR) T-cell TherapiesNCT06652633LKFTPhase 3Recruiting2039-07Estimated
A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Cutaneous Venous MalformationsNCT06653842PVLAPhase 2Active not recruiting2025-11-21Actual
B-FREE Chronic Babesiosis StudyNCT0665635160 Degrees Pharmaceuticals LLCPhase 2Recruiting2027-02Estimated
ALTO-100 in Bipolar Disorder With Depression (BD-D)NCT06656416Alto NeurosciencePhase 2Recruiting2026-08Estimated
A Study to Evaluate the Safety and Efficacy of NDV-01 in Participants With NMIBCNCT06663137RLMDPhase 2Recruiting2027-11Estimated
A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1NCT06667453PEPGPhase 2Recruiting2027-03Estimated
A Study to Evaluate VXA-CoV2-3.3 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 InfectionNCT06672055VaxartPhase 2Active not recruiting2027-05Estimated
A Phase 3 Study of NTLA-2001 in ATTRv-PNNCT06672237Intellia TherapeuticsPhase 3Recruiting2027-07Estimated
A Rollover Study to Evaluate the Long-Term Safety and Efficacy of AtaciceptNCT06674577VERAPhase 2Enrolling by invitation2031-05-21Estimated
A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular CarcinomaNCT06679985CHRSPhase 2Active not recruiting2027-09Estimated
A Study of TPST-1120 With Atezolizumab Plus Bevacizumab in Patients With Unresectable or Metastatic HCC Not Previously Treated With Systemic TherapyNCT06680258Tempest TherapeuticsPhase 3Not yet recruiting2028-12Estimated

Primary completion marks the end of data collection for the main study measures, not a results publication date.